Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for 600529.SS and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for 600529.SS and 80,000+ other tickers.
See exactly how 600529.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 600529.SS and 80,000+ other tickers.
Shandong Pharmaceutical Glass Co., Ltd (SPG), headquartered in Zibo, China, is a manufacturer and supplier specializing in pharmaceutical glass packaging and related butyl rubber products. The company's extensive product portfolio encompasses a diverse range of glass packaging solutions. This includes essential items like molded injection vials, tubular glass vials, and ampoules, alongside various borosilicate glass products. SPG also supplies specialized containers such as amber, cobalt blue, and green bottles, as well as clear cosmetic and food-grade bottles. Beyond glass, SPG produces…
No recent news available.